PF-04958242

Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale
Endpoints
Mon, 03/12/18 - 09:38 am
Biogen
schizophrenia
clinical trials
Pfizer
PF-04958242